
Precision base editing for genetic medicines
Beam Therapeutics advances base-editing technologies for precise single-base changes in vivo. Its platform is therapeutic-delivery focused, not discovery-oriented like Algen’s AlgenCRISPR plus AlgenBrain combination. Pricing and business models center on clinical assets rather than platform partnerships for target deconvolution.
Beam Therapeutics advances science with base editing, an emerging class of investigational precision genetic medicines designed to overcome limitations of existing approaches. Their delivery strategy establishes clinically validated technologies including electroporation, nonviral and viral modalities. The company maintains research facilities in Cambridge, MA and a manufacturing site in Durham, NC while progressing a pipeline through clinical trials.
Free

Culturally responsive mental health resources and therapist directory for Black women and girls.

NYC-based online therapy with licensed therapists accepting insurance for anxiety, trauma, and life transitions.
Online therapy for teens and parents via text, phone, and video from licensed therapists.